Talphera (NASDAQ:TLPH) Posts Earnings Results, Beats Expectations By $0.02 EPS

Talphera (NASDAQ:TLPH) issued its earnings results on Monday. The company reported ($0.06) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.08) by $0.02, FiscalAI reports.

Talphera Stock Performance

TLPH stock opened at $0.83 on Monday. Talphera has a one year low of $0.38 and a one year high of $1.57. The firm’s fifty day moving average is $0.89 and its 200 day moving average is $1.05. The firm has a market cap of $38.82 million, a PE ratio of -2.19 and a beta of 0.47.

Insider Activity

In other Talphera news, insider Shakil Aslam purchased 35,000 shares of the business’s stock in a transaction that occurred on Thursday, February 12th. The stock was purchased at an average price of $0.81 per share, for a total transaction of $28,350.00. Following the purchase, the insider directly owned 83,178 shares in the company, valued at approximately $67,374.18. This trade represents a 72.65% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Vincent J. Angotti purchased 105,364 shares of the stock in a transaction on Thursday, February 12th. The shares were acquired at an average price of $0.81 per share, for a total transaction of $85,344.84. Following the transaction, the chief executive officer directly owned 586,954 shares of the company’s stock, valued at $475,432.74. This represents a 21.88% increase in their position. The SEC filing for this purchase provides additional information. In the last 90 days, insiders acquired 220,364 shares of company stock valued at $178,495. Insiders own 5.70% of the company’s stock.

Hedge Funds Weigh In On Talphera

A number of large investors have recently added to or reduced their stakes in the stock. Group One Trading LLC lifted its stake in Talphera by 3,224.0% in the 3rd quarter. Group One Trading LLC now owns 30,415 shares of the company’s stock valued at $27,000 after buying an additional 29,500 shares in the last quarter. Virtu Financial LLC acquired a new position in shares of Talphera during the third quarter valued at approximately $29,000. Persistent Asset Partners Ltd purchased a new position in shares of Talphera in the fourth quarter valued at approximately $42,000. Mariner LLC boosted its stake in shares of Talphera by 132.0% in the fourth quarter. Mariner LLC now owns 58,000 shares of the company’s stock worth $66,000 after acquiring an additional 33,000 shares during the last quarter. Finally, Dauntless Investment Group LLC acquired a new stake in shares of Talphera in the third quarter worth approximately $89,000. 37.67% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reiterated a “sell (d-)” rating on shares of Talphera in a research note on Wednesday, January 21st. One analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, Talphera has an average rating of “Hold” and a consensus price target of $6.00.

Talphera Company Profile

Talphera, Inc, a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. Its lead product candidate is Niyad, a lyophilized formulation of nafamostat, which is under an investigational device exemption as an anticoagulant for the extracorporeal circuit. It is also developing LTX-608, an anti-inflammatory and antiviral potential for the treatment of multiple conditions, including disseminated intravascular coagulation (DIC), acute respiratory distress syndrome (ARDS), and acute pancreatitis; Fedsyra, a pre-filled ephedrine syringe; and PFS-02, a pre-filled phenylephrine syringe.